Allene M. Diaz is Director at IONIS PHARMACEUTICALS INC (IONS). They have made 1 open-market trade across 1 company since 2023, most recently 2026-07-07.
CIK 0001773314
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRSN | 14,467 | $421K |
| IONS | 3,811 | $164K |
| Total | $584K |
Shares reported on the most recent Form 4, priced at the 2026-07-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IONS | SELL · 10b5-1 | 2026-07-07 | 2026-07-09 | $85.42 | $864K | -17.1% | -11.7% | -31.4% |
| IONS | SELL | 2026-03-03 | 2026-03-05 | $79.35 | $4.4M | -2.2% | +0.5% | -0.2% |
| IONS | SELL · 10b5-1 | 2025-08-22 | 2025-08-26 | $42.53 | $121K | +44.7% | +49.3% | +86.2% |
| IONS | SELL · 10b5-1 | 2024-07-16 | 2024-07-17 | $49.49 | $81K | +4.5% | -3.3% | -21.3% |
| IONS | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $41.05 | $27K | +1.1% | -0.6% | +14.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.